JP2021501318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021501318A5 JP2021501318A5 JP2020523389A JP2020523389A JP2021501318A5 JP 2021501318 A5 JP2021501318 A5 JP 2021501318A5 JP 2020523389 A JP2020523389 A JP 2020523389A JP 2020523389 A JP2020523389 A JP 2020523389A JP 2021501318 A5 JP2021501318 A5 JP 2021501318A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- virus
- disease
- markers
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 186
- 238000000034 method Methods 0.000 claims description 128
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 84
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 84
- 201000010099 disease Diseases 0.000 claims description 67
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 67
- 239000000523 sample Substances 0.000 claims description 60
- 102100024263 CD160 antigen Human genes 0.000 claims description 54
- 101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims description 54
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims description 54
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims description 54
- 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 claims description 45
- 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 claims description 45
- 101100445364 Mus musculus Eomes gene Proteins 0.000 claims description 41
- 101100445365 Xenopus laevis eomes gene Proteins 0.000 claims description 41
- 101150063370 Gzmb gene Proteins 0.000 claims description 35
- 101150043363 GZMK gene Proteins 0.000 claims description 34
- 239000003550 marker Substances 0.000 claims description 32
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 31
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 31
- 241000700605 Viruses Species 0.000 claims description 27
- 230000009385 viral infection Effects 0.000 claims description 24
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 22
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 22
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 22
- 208000036142 Viral infection Diseases 0.000 claims description 22
- 102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 claims description 21
- 101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 claims description 21
- 102100021260 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Human genes 0.000 claims description 19
- 101000894906 Homo sapiens Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Proteins 0.000 claims description 19
- 102000004503 Perforin Human genes 0.000 claims description 19
- 108010056995 Perforin Proteins 0.000 claims description 19
- KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 claims description 19
- 210000004027 cell Anatomy 0.000 claims description 19
- 229930192851 perforin Natural products 0.000 claims description 19
- 102000008203 CTLA-4 Antigen Human genes 0.000 claims description 18
- 108010021064 CTLA-4 Antigen Proteins 0.000 claims description 18
- 229940045513 CTLA4 antagonist Drugs 0.000 claims description 18
- 241000701161 unidentified adenovirus Species 0.000 claims description 18
- 101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 claims description 17
- 101000599037 Homo sapiens Zinc finger protein Helios Proteins 0.000 claims description 17
- 206010028980 Neoplasm Diseases 0.000 claims description 17
- 102100036840 T-box transcription factor TBX21 Human genes 0.000 claims description 17
- 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 claims description 16
- 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 claims description 16
- 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 claims description 16
- 230000001973 epigenetic effect Effects 0.000 claims description 16
- 102100027207 CD27 antigen Human genes 0.000 claims description 15
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 15
- 101001045751 Homo sapiens Hepatocyte nuclear factor 1-alpha Proteins 0.000 claims description 14
- 101001046687 Homo sapiens Integrin alpha-E Proteins 0.000 claims description 14
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims description 14
- 102100022341 Integrin alpha-E Human genes 0.000 claims description 14
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 14
- 238000003753 real-time PCR Methods 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 14
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 12
- 101150115210 PTGER2 gene Proteins 0.000 claims description 12
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 claims description 12
- 108090000246 Histone acetyltransferases Proteins 0.000 claims description 11
- 102000003893 Histone acetyltransferases Human genes 0.000 claims description 11
- 102000017578 LAG3 Human genes 0.000 claims description 11
- 101150030213 Lag3 gene Proteins 0.000 claims description 11
- 108010077544 Chromatin Proteins 0.000 claims description 10
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims description 10
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 10
- 210000003483 chromatin Anatomy 0.000 claims description 10
- 239000013068 control sample Substances 0.000 claims description 10
- 239000003112 inhibitor Substances 0.000 claims description 10
- 230000037361 pathway Effects 0.000 claims description 10
- 241001529453 unidentified herpesvirus Species 0.000 claims description 10
- 102000006354 HLA-DR Antigens Human genes 0.000 claims description 9
- 108010058597 HLA-DR Antigens Proteins 0.000 claims description 9
- 201000011510 cancer Diseases 0.000 claims description 9
- 230000001684 chronic effect Effects 0.000 claims description 9
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 claims description 8
- 241000701022 Cytomegalovirus Species 0.000 claims description 8
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 claims description 8
- 108010002350 Interleukin-2 Proteins 0.000 claims description 8
- 102000000588 Interleukin-2 Human genes 0.000 claims description 8
- 208000006454 hepatitis Diseases 0.000 claims description 8
- 231100000283 hepatitis Toxicity 0.000 claims description 8
- 102100021396 Cell surface glycoprotein CD200 receptor 1 Human genes 0.000 claims description 7
- 101000969553 Homo sapiens Cell surface glycoprotein CD200 receptor 1 Proteins 0.000 claims description 7
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 7
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 7
- 230000001154 acute effect Effects 0.000 claims description 7
- 230000003247 decreasing effect Effects 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 241000712461 unidentified influenza virus Species 0.000 claims description 7
- 102100022464 5'-nucleotidase Human genes 0.000 claims description 6
- 206010003445 Ascites Diseases 0.000 claims description 6
- 102000001398 Granzyme Human genes 0.000 claims description 6
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims description 6
- 101000648265 Homo sapiens Thymocyte selection-associated high mobility group box protein TOX Proteins 0.000 claims description 6
- 241001505332 Polyomavirus sp. Species 0.000 claims description 6
- 102100028788 Thymocyte selection-associated high mobility group box protein TOX Human genes 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 238000011225 antiretroviral therapy Methods 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 210000004698 lymphocyte Anatomy 0.000 claims description 6
- 210000003097 mucus Anatomy 0.000 claims description 6
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 claims description 6
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 6
- 241001430294 unidentified retrovirus Species 0.000 claims description 6
- -1 Helios Proteins 0.000 claims description 5
- 208000002151 Pleural effusion Diseases 0.000 claims description 5
- 210000002751 lymph Anatomy 0.000 claims description 5
- 102100038778 Amphiregulin Human genes 0.000 claims description 4
- 108010033760 Amphiregulin Proteins 0.000 claims description 4
- 102000049320 CD36 Human genes 0.000 claims description 4
- 108010045374 CD36 Antigens Proteins 0.000 claims description 4
- 108091033409 CRISPR Proteins 0.000 claims description 4
- 201000009030 Carcinoma Diseases 0.000 claims description 4
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims description 4
- 108060005986 Granzyme Proteins 0.000 claims description 4
- 241000711549 Hepacivirus C Species 0.000 claims description 4
- 241000724675 Hepatitis E virus Species 0.000 claims description 4
- 208000037262 Hepatitis delta Diseases 0.000 claims description 4
- 241000724709 Hepatitis delta virus Species 0.000 claims description 4
- 241000709721 Hepatovirus A Species 0.000 claims description 4
- 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 claims description 4
- 101000971533 Homo sapiens Killer cell lectin-like receptor subfamily G member 1 Proteins 0.000 claims description 4
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 claims description 4
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims description 4
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims description 4
- 241000829111 Human polyomavirus 1 Species 0.000 claims description 4
- 241000829106 Human polyomavirus 3 Species 0.000 claims description 4
- 241001237553 Human polyomavirus 6 Species 0.000 claims description 4
- 241000629695 Human polyomavirus 9 Species 0.000 claims description 4
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims description 4
- 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 claims description 4
- 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 claims description 4
- 102000003814 Interleukin-10 Human genes 0.000 claims description 4
- 108090000174 Interleukin-10 Proteins 0.000 claims description 4
- 102100030703 Interleukin-22 Human genes 0.000 claims description 4
- 241000701460 JC polyomavirus Species 0.000 claims description 4
- 102100021457 Killer cell lectin-like receptor subfamily G member 1 Human genes 0.000 claims description 4
- 241000713666 Lentivirus Species 0.000 claims description 4
- 102100035304 Lymphotactin Human genes 0.000 claims description 4
- 208000032818 Microsatellite Instability Diseases 0.000 claims description 4
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 4
- 208000030852 Parasitic disease Diseases 0.000 claims description 4
- 101100393514 Rattus norvegicus Gzmm gene Proteins 0.000 claims description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 4
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 4
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims description 4
- 108010074108 interleukin-21 Proteins 0.000 claims description 4
- 201000001441 melanoma Diseases 0.000 claims description 4
- 230000008685 targeting Effects 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 241000224422 Acanthamoeba Species 0.000 claims description 3
- 208000035143 Bacterial infection Diseases 0.000 claims description 3
- 241000726108 Blastocystis Species 0.000 claims description 3
- 101100510617 Caenorhabditis elegans sel-8 gene Proteins 0.000 claims description 3
- 241000713730 Equine infectious anemia virus Species 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 241000682990 Pegivirus A Species 0.000 claims description 3
- 241000223821 Plasmodium malariae Species 0.000 claims description 3
- 241000533331 Salmonella bongori Species 0.000 claims description 3
- 241001138501 Salmonella enterica Species 0.000 claims description 3
- 241000224527 Trichomonas vaginalis Species 0.000 claims description 3
- 241000607626 Vibrio cholerae Species 0.000 claims description 3
- 244000000013 helminth Species 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 229940118768 plasmodium malariae Drugs 0.000 claims description 3
- 229940118696 vibrio cholerae Drugs 0.000 claims description 3
- DTTONLKLWRTCAB-UDFURZHRSA-N (1s,3e,5r,7r)-3-[(3,4-dihydroxyphenyl)-hydroxymethylidene]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-[(2s)-5-methyl-2-prop-1-en-2-ylhex-4-enyl]bicyclo[3.3.1]nonane-2,4,9-trione Chemical compound O=C([C@@]1(C(C)(C)[C@H](CC=C(C)C)C[C@](C2=O)(C1=O)C[C@H](CC=C(C)C)C(C)=C)CC=C(C)C)\C2=C(\O)C1=CC=C(O)C(O)=C1 DTTONLKLWRTCAB-UDFURZHRSA-N 0.000 claims description 2
- OMKHWTRUYNAGFG-IEBDPFPHSA-N 3-deazaneplanocin a Chemical compound C1=NC=2C(N)=NC=CC=2N1[C@@H]1C=C(CO)[C@@H](O)[C@H]1O OMKHWTRUYNAGFG-IEBDPFPHSA-N 0.000 claims description 2
- FAWSUKOIROHXAP-NPMXOYFQSA-N 4-[(2s,4r)-1-acetyl-4-(4-chloroanilino)-2-methyl-3,4-dihydro-2h-quinolin-6-yl]benzoic acid Chemical compound N([C@@H]1C[C@@H](N(C2=CC=C(C=C21)C=1C=CC(=CC=1)C(O)=O)C(C)=O)C)C1=CC=C(Cl)C=C1 FAWSUKOIROHXAP-NPMXOYFQSA-N 0.000 claims description 2
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 claims description 2
- 241001664176 Alpharetrovirus Species 0.000 claims description 2
- 241000934146 Balamuthia mandrillaris Species 0.000 claims description 2
- 241001231757 Betaretrovirus Species 0.000 claims description 2
- 206010005003 Bladder cancer Diseases 0.000 claims description 2
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 2
- 238000010354 CRISPR gene editing Methods 0.000 claims description 2
- 241000589875 Campylobacter jejuni Species 0.000 claims description 2
- 102000019034 Chemokines Human genes 0.000 claims description 2
- 108010012236 Chemokines Proteins 0.000 claims description 2
- 241000193155 Clostridium botulinum Species 0.000 claims description 2
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 2
- 241000223935 Cryptosporidium Species 0.000 claims description 2
- 102000004127 Cytokines Human genes 0.000 claims description 2
- 108090000695 Cytokines Proteins 0.000 claims description 2
- 108010009540 DNA (Cytosine-5-)-Methyltransferase 1 Proteins 0.000 claims description 2
- 102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 claims description 2
- 241001663879 Deltaretrovirus Species 0.000 claims description 2
- 241000157306 Dientamoeba fragilis Species 0.000 claims description 2
- 206010058314 Dysplasia Diseases 0.000 claims description 2
- 101710201246 Eomesodermin Proteins 0.000 claims description 2
- 102100030751 Eomesodermin homolog Human genes 0.000 claims description 2
- 241001663878 Epsilonretrovirus Species 0.000 claims description 2
- 241001663880 Gammaretrovirus Species 0.000 claims description 2
- QDKLRKZQSOQWJQ-JGWHSXGBSA-N Garcinol Natural products O=C([C@@]1(C(C)(C)[C@@H](CC=C(C)C)C[C@](C=2O)(C1=O)C[C@H](CC=C(C)C)C(C)=C)CC=C(C)C)C=2C(=O)C1=CC=C(O)C(O)=C1 QDKLRKZQSOQWJQ-JGWHSXGBSA-N 0.000 claims description 2
- 241000224467 Giardia intestinalis Species 0.000 claims description 2
- 108050003624 Granzyme M Proteins 0.000 claims description 2
- 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims description 2
- 241000700721 Hepatitis B virus Species 0.000 claims description 2
- 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 claims description 2
- 102100022846 Histone acetyltransferase KAT2B Human genes 0.000 claims description 2
- 102100022537 Histone deacetylase 6 Human genes 0.000 claims description 2
- 108010033040 Histones Proteins 0.000 claims description 2
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims description 2
- 101001047006 Homo sapiens Histone acetyltransferase KAT2B Proteins 0.000 claims description 2
- 101000899330 Homo sapiens Histone deacetylase 6 Proteins 0.000 claims description 2
- 101001117519 Homo sapiens Prostaglandin E2 receptor EP2 subtype Proteins 0.000 claims description 2
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims description 2
- 241000701041 Human betaherpesvirus 7 Species 0.000 claims description 2
- 241001502974 Human gammaherpesvirus 8 Species 0.000 claims description 2
- 241000701027 Human herpesvirus 6 Species 0.000 claims description 2
- 241001500351 Influenzavirus A Species 0.000 claims description 2
- 241001500350 Influenzavirus B Species 0.000 claims description 2
- 241001500343 Influenzavirus C Species 0.000 claims description 2
- 241000401052 Influenzavirus D Species 0.000 claims description 2
- 241000222722 Leishmania <genus> Species 0.000 claims description 2
- 241000186779 Listeria monocytogenes Species 0.000 claims description 2
- 206010027480 Metastatic malignant melanoma Diseases 0.000 claims description 2
- 206010050513 Metastatic renal cell carcinoma Diseases 0.000 claims description 2
- WWGBHDIHIVGYLZ-UHFFFAOYSA-N N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl ester Chemical compound C1=CC(NC(=O)OC(C)(C)C)=CC=C1C1=CC(C(=O)NCCCCCCC(=O)NO)=NO1 WWGBHDIHIVGYLZ-UHFFFAOYSA-N 0.000 claims description 2
- QGZYDVAGYRLSKP-UHFFFAOYSA-N N-[7-(hydroxyamino)-7-oxoheptyl]-2-(N-phenylanilino)-5-pyrimidinecarboxamide Chemical compound N1=CC(C(=O)NCCCCCCC(=O)NO)=CN=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 QGZYDVAGYRLSKP-UHFFFAOYSA-N 0.000 claims description 2
- 241000224438 Naegleria fowleri Species 0.000 claims description 2
- 206010033128 Ovarian cancer Diseases 0.000 claims description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
- 241000223960 Plasmodium falciparum Species 0.000 claims description 2
- 241000223801 Plasmodium knowlesi Species 0.000 claims description 2
- 241001505293 Plasmodium ovale Species 0.000 claims description 2
- 241000223810 Plasmodium vivax Species 0.000 claims description 2
- 102100024448 Prostaglandin E2 receptor EP2 subtype Human genes 0.000 claims description 2
- 208000006265 Renal cell carcinoma Diseases 0.000 claims description 2
- 241000713675 Spumavirus Species 0.000 claims description 2
- 241000191967 Staphylococcus aureus Species 0.000 claims description 2
- 241000193996 Streptococcus pyogenes Species 0.000 claims description 2
- 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims description 2
- 241000223997 Toxoplasma gondii Species 0.000 claims description 2
- 241001654786 Trichodysplasia spinulosa-associated polyomavirus Species 0.000 claims description 2
- 241000223104 Trypanosoma Species 0.000 claims description 2
- 241000223109 Trypanosoma cruzi Species 0.000 claims description 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 230000003321 amplification Effects 0.000 claims description 2
- 238000003556 assay Methods 0.000 claims description 2
- 229940109262 curcumin Drugs 0.000 claims description 2
- 235000012754 curcumin Nutrition 0.000 claims description 2
- 239000004148 curcumin Substances 0.000 claims description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 2
- 230000003511 endothelial effect Effects 0.000 claims description 2
- LMFLOMBYUXRHIL-UHFFFAOYSA-N garcifuran-A Natural products COC1=C(O)C(OC)=CC(C=2C(=C3C=COC3=CC=2)O)=C1 LMFLOMBYUXRHIL-UHFFFAOYSA-N 0.000 claims description 2
- 229940085435 giardia lamblia Drugs 0.000 claims description 2
- GRBCIRZXESZBGJ-UHFFFAOYSA-N guttiferone F Natural products CC(=CCCC(C(=C)C)C12CC(CC=C(C)C)C(C)(C)C(CC=C(C)C)(C(=O)C(=C1O)C(=O)c3ccc(O)c(O)c3)C2=O)C GRBCIRZXESZBGJ-UHFFFAOYSA-N 0.000 claims description 2
- 201000000459 head and neck squamous cell carcinoma Diseases 0.000 claims description 2
- 230000036541 health Effects 0.000 claims description 2
- 239000003276 histone deacetylase inhibitor Substances 0.000 claims description 2
- 230000001394 metastastic effect Effects 0.000 claims description 2
- 208000021039 metastatic melanoma Diseases 0.000 claims description 2
- 206010061289 metastatic neoplasm Diseases 0.000 claims description 2
- 230000011987 methylation Effects 0.000 claims description 2
- 238000007069 methylation reaction Methods 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 230000002250 progressing effect Effects 0.000 claims description 2
- 229940121649 protein inhibitor Drugs 0.000 claims description 2
- 239000012268 protein inhibitor Substances 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 201000005112 urinary bladder cancer Diseases 0.000 claims description 2
- 210000001635 urinary tract Anatomy 0.000 claims description 2
- WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 claims description 2
- 229960000237 vorinostat Drugs 0.000 claims description 2
- 241000224016 Plasmodium Species 0.000 claims 6
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 2
- 241000224432 Entamoeba histolytica Species 0.000 claims 1
- 208000007502 anemia Diseases 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 229940007078 entamoeba histolytica Drugs 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 210000004880 lymph fluid Anatomy 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 210000004910 pleural fluid Anatomy 0.000 claims 1
- 230000009467 reduction Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 241000224489 Amoeba Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 108010034145 Helminth Proteins Proteins 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241000869417 Trematodes Species 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 238000012015 optical character recognition Methods 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762578193P | 2017-10-27 | 2017-10-27 | |
| US201762578212P | 2017-10-27 | 2017-10-27 | |
| US62/578,193 | 2017-10-27 | ||
| US62/578,212 | 2017-10-27 | ||
| US201862660754P | 2018-04-20 | 2018-04-20 | |
| US62/660,754 | 2018-04-20 | ||
| US201862661467P | 2018-04-23 | 2018-04-23 | |
| US62/661,467 | 2018-04-23 | ||
| PCT/US2018/057850 WO2019084493A1 (en) | 2017-10-27 | 2018-10-26 | METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SUSPECTED T CELLS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021501318A JP2021501318A (ja) | 2021-01-14 |
| JP2021501318A5 true JP2021501318A5 (cg-RX-API-DMAC7.html) | 2021-12-09 |
| JP7430136B2 JP7430136B2 (ja) | 2024-02-09 |
Family
ID=66246753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523389A Active JP7430136B2 (ja) | 2017-10-27 | 2018-10-26 | 疲弊したｔ細胞に関連する疾患を治療するための方法および組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11906511B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3701041A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7430136B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019084493A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD1083956S1 (en) * | 2018-12-10 | 2025-07-15 | Icahn School Of Medicine At Mount Sinai | Display screen with a graphical user interface |
| WO2020246846A1 (ko) * | 2019-06-05 | 2020-12-10 | 연세대학교 산학협력단 | Tox에 기초한 면역 항암 요법에 대한 치료 반응 예측 방법 |
| EP3998082A4 (en) * | 2019-07-10 | 2024-02-07 | National Cancer Center | SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING CANCER CELLS |
| WO2021092224A1 (en) * | 2019-11-05 | 2021-05-14 | Cofactor Genomics, Inc. | Methods and systems of processing complex data sets using artificial intelligence and deconvolution |
| CN111154835A (zh) * | 2020-01-19 | 2020-05-15 | 广州基迪奥生物科技有限公司 | 一种ATAC-seq测序文库的构建方法 |
| JP2023521345A (ja) * | 2020-04-07 | 2023-05-24 | ユニバーシティー ヘルス ネットワーク | Ｓａｇａ（ｓｐｔ－ａｄａ－ｇｃｎ５－アセチルトランスフェラーゼ）複合体の破壊による、ｃｄ８＋ ｔ細胞の活性化及び細胞溶解活性を向上させるための組成物及び方法 |
| CA3158133A1 (en) | 2020-04-28 | 2021-11-04 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| CN111748627A (zh) * | 2020-07-02 | 2020-10-09 | 北京化工大学 | 膀胱癌耗竭型t细胞亚群、其特征基因及其应用 |
| EP4216999A4 (en) * | 2020-09-23 | 2025-10-15 | Univ Columbia | METABOLIC AUGMENTATION TO PROMOTE AND ENHANCE THE IMMUNE RESPONSE BY REPOPULATION OF TCF1+ T CELLS |
| CN112501292B (zh) * | 2020-11-09 | 2022-12-02 | 中国人民解放军海军军医大学 | cFAM210A在制备肝癌诊断或术后预测试剂盒以及药物中的应用 |
| JP2024510931A (ja) * | 2021-03-03 | 2024-03-12 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 新規結合親和性を有するポリペプチド構築物およびその使用 |
| WO2023023269A1 (en) * | 2021-08-20 | 2023-02-23 | The Board Of Trustees Of The Leland Stanford Junior University | Identification of pathogenic immune cell subsets in checkpoint inhibitor-induced myocarditis |
| WO2023034530A1 (en) * | 2021-09-02 | 2023-03-09 | Teon Therapeutics, Inc. | Methods of improving growth and function of immune cells |
| US20250003007A1 (en) * | 2021-10-04 | 2025-01-02 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Dna methylation signatures for predicting response to immunotherapy |
| AU2022374955A1 (en) * | 2021-10-26 | 2024-05-23 | Assistance Publique - Hôpitaux De Paris | T cell immunotherapy derived from highly functional autologous stem cell memory T cells |
| JP2023064788A (ja) * | 2021-10-27 | 2023-05-12 | 国立大学法人京都大学 | Ｔ細胞の評価方法及びｔ細胞評価用の組成物 |
| CN115040538A (zh) * | 2022-05-23 | 2022-09-13 | 重庆医科大学 | 人cxcr5＋cd8＋t细胞在制备治疗慢性乙型肝炎的药物中的应用 |
| CN114752628B (zh) * | 2022-05-30 | 2023-06-30 | 四川大学华西医院 | C57bl/6小鼠多发性骨髓瘤模型的构建方法及应用 |
| CN115029429B (zh) * | 2022-06-02 | 2022-11-22 | 中国人民解放军总医院第五医学中心 | 炎症相关蛋白联合在预测art治疗敏感性中的应用 |
| CN115040663B (zh) * | 2022-06-15 | 2023-12-12 | 上海交通大学医学院附属仁济医院 | 溶质载体家族38成员2在制备多发性骨髓瘤治疗药物中的应用 |
| CN115058504B (zh) * | 2022-07-14 | 2025-07-04 | 广州医科大学 | 膀胱癌th17 cd4+t细胞亚群及其特征基因与应用 |
| WO2024074713A1 (en) * | 2022-10-07 | 2024-04-11 | Institut National de la Santé et de la Recherche Médicale | Method to generate improving car-t cells |
| CN120188221A (zh) * | 2022-11-01 | 2025-06-20 | 百进生物科技公司 | 分析细胞成分的每个细胞共表达 |
| CN119700985A (zh) * | 2023-09-22 | 2025-03-28 | 清华大学 | Bcor和Zc3h12a在预防和治疗慢性感染中的用途 |
| CN117017991A (zh) * | 2023-09-26 | 2023-11-10 | 中山大学附属第三医院 | Hdac6选择性抑制剂在制备慢性乙型病毒性肝炎抗病毒治疗药物中的应用 |
| CN118818055A (zh) * | 2024-06-05 | 2024-10-22 | 复旦大学附属华山医院 | 用于筛选胶质瘤dc疫苗潜在受益人群的试剂盒及应用 |
| CN120015309B (zh) * | 2025-01-14 | 2025-12-12 | 中国人民解放军军事科学院军事医学研究院 | 用于急性高原反应（ams）易感性分群的装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2703947C (en) | 2007-10-26 | 2018-12-04 | Governing Council Of The University Of Toronto | Therapeutic and diagnostic methods using tim-3 |
| US10927410B2 (en) | 2014-10-17 | 2021-02-23 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators |
| WO2017075451A1 (en) * | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses by detecting and targeting pou2af1 |
| WO2017165412A2 (en) * | 2016-03-21 | 2017-09-28 | Dana-Farber Cancer Institute, Inc. | T-cell exhaustion state-specific gene expression regulators and uses thereof |
-
2018
- 2018-10-26 JP JP2020523389A patent/JP7430136B2/ja active Active
- 2018-10-26 WO PCT/US2018/057850 patent/WO2019084493A1/en not_active Ceased
- 2018-10-26 US US16/759,676 patent/US11906511B2/en active Active
- 2018-10-26 EP EP18870493.6A patent/EP3701041A4/en active Pending
-
2024
- 2024-01-03 US US18/403,429 patent/US20240264151A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021501318A5 (cg-RX-API-DMAC7.html) | ||
| AU2019249422B2 (en) | Methylation markers and targeted methylation probe panels | |
| Bas et al. | Utility of the housekeeping genes 18S rRNA, β‐actin and glyceraldehyde‐3‐phosphate‐dehydrogenase for normalization in real‐time quantitative reverse transcriptase‐polymerase chain reaction analysis of gene expression in human T lymphocytes | |
| Ekiz et al. | MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers | |
| US12105089B2 (en) | Cell atlas of the healthy and ulcerative colitis human colon | |
| Wang | The opening of pandora's box: an emerging role of long noncoding RNA in viral infections | |
| US20190263912A1 (en) | Modulation of intestinal epithelial cell differentiation, maintenance and/or function through t cell action | |
| Fletcher et al. | Intrahepatic transcriptional signature associated with response to interferon-α treatment in the woodchuck model of chronic hepatitis B | |
| US20190144942A1 (en) | Methods for identifying and modulating immune phenotypes | |
| Davar et al. | Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial | |
| WO2019079647A2 (en) | IA STATISTICS FOR DEEP LEARNING AND PROBABILISTIC PROGRAMMING, ADVANCED, IN BIOSCIENCES | |
| Ghosh et al. | Strong correlation between air-liquid interface cultures and in vivo transcriptomics of nasal brush biopsy | |
| TW201739919A (zh) | 患者特異性新抗原決定基之高通量識別以作為用於癌症免疫療法之治療劑 | |
| US20230223105A1 (en) | Mitigation of statistical bias in genetic sampling | |
| Guo et al. | Comprehensive analysis of m6A RNA methylation regulators and the immune microenvironment to aid immunotherapy in pancreatic cancer | |
| US20240167933A1 (en) | Flow cytometry immunoprofiling of peripheral blood | |
| Burchill et al. | Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes | |
| KR20190032374A (ko) | 엑소좀-안내 암 치료(exosome-guided treatment of cancer) | |
| Cristalli et al. | Targeting DNA methylation machinery in pediatric solid tumors | |
| WO2005021745A1 (ja) | 肝細胞癌に関連する遺伝子 | |
| US20220136070A1 (en) | Methods and systems for characterizing tumor response to immunotherapy using an immunogenic profile | |
| CN116287158A (zh) | 一种新抗原鉴定和疗效预测方法 | |
| Hou et al. | Analysis of the transcriptome and immune function of monocytes during IFNα-based therapy in chronic HCV revealed induction of TLR7 responsiveness | |
| Razzuoli et al. | Reverse transcription real‐time PCR for detection of porcine interferon α and β genes | |
| Li et al. | Identification of immunosenescence of unconventional T cells in hepatocellular carcinoma |